Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by David S Rickman
Exquisite Sensitivity of TP53 Mutant and Basal Breast Cancers to a Dose-Dense Epirubicin−Cyclophosphamide Regimen
PLoS Medicine
Biochemistry
Biotechnology
Molecular Biology
Cell Biology
Medicine
Related publications
P2-033Neoadjuvant Doxorubicin and Cyclophosphamide Followed by Paclitaxel Dose Dense in Stage III Breast Cancer
Annals of Oncology
Medicine
Oncology
Hematology
Epirubicin and Cyclophosphamide, Methotrexate, and Fluorouracil as Adjuvant Therapy for Early Breast Cancer
New England Journal of Medicine
Medicine
Epirubicin/Cyclophosphamide Followed by Docetaxel as Primary Systemic Therapy in Breast Cancer
Annals of Cancer Research and Therapy
Cancer Research
Oncology
Pharmacology
Are Basal-Like and Non-Basal-Like Triple-Negative Breast Cancers Really Different?
Journal of Oncology
Oncology
MA16.04 Clinical and Molecular Characteristics of EGFR Mutant Lung Cancers With Concurrent TP53 and RB1 Mutations
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
A Feasibility Study of Bevacizumab Plus Dose-Dense Doxorubicin-Cyclophosphamide (AC) Followed by Nanoparticle Albumin-Bound Paclitaxel in Early-Stage Breast Cancer
Clinical Cancer Research
Cancer Research
Oncology
Ambra1 Modulates the Sensitivity of Breast Cancer Cells to Epirubicin by Regulating Autophagy via ATG12
Cancer Science
Cancer Research
Medicine
Oncology
Gene Expression Profiling Shows Medullary Breast Cancer Is a Subgroup of Basal Breast Cancers
Cancer Research
Cancer Research
Oncology
Feasibility and Safety of a Reduced Duration of Therapy of Colony-Stimulating Factor in a Dose-Dense Regimen
Supportive Care in Cancer
Oncology
